Title: Why are most phospholipidosis inducers also hERG blockers?
Journal: Archives of toxicology 20171201
Title: Trace analysis of three antihistamines in human urine by on-line single drop liquid-liquid-liquid microextraction coupled to sweeping micellar electrokinetic chromatography and its application to pharmacokinetic study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120901
Title: Cetirizine and loratadine: minimal risk of QT prolongation.
Journal: Prescrire international 20100201
Title: Reversible anti-settlement activity against Amphibalanus (=Balanus) amphitrite, Bugula neritina, and Hydroides elegans by a nontoxic pharmaceutical compound, mizolastine.
Journal: Biofouling 20091101
Title: [Efficacy and safety of Mizolastine in the treatment of perennial allergic rhinitis].
Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20070601
Title: Development of a CZE method for the determination of mizolastine and its impurities in pharmaceutical preparations using response surface methodology.
Journal: Electrophoresis 20070201
Title: Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
Journal: Journal of medicinal chemistry 20061116
Title: Allergic reactions due to mizolastine.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060801
Title: [Mizolastine improves the quality of life in patients with perennial allergic rhinitis: a randomized, double blind, controlled study].
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20060701
Title: Influence of mizolastine on antigen-induced activation of signalling pathways in murine mast cells.
Journal: Clinical and experimental dermatology 20060301
Title: [Inhibitory effects of mizolastine on substance P-induced production of leukotriene B4 and interleukin 5 in mouse skin].
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20060301
Title: Hypersensitivity reaction to mizolastine: study of cross reactions.
Journal: Journal of investigational allergology & clinical immunology 20060101
Title: The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine.
Journal: Clinical and experimental dermatology 20050301
Title: [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20041201
Title: Anaphylaxis to mizolastine.
Journal: The Journal of allergy and clinical immunology 20041001
Title: Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
Journal: Fundamental & clinical pharmacology 20040801
Title: [Clinical examination of mizolastine in the seasonal allergic rhinitis].
Journal: Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology 20040801
Title: Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
Journal: European annals of allergy and clinical immunology 20040401
Title: Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20040201
Title: Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Journal: Bioorganic & medicinal chemistry letters 20030818
Title: [Antihistaminics. Side effects also after raising dosage at the placebo level].
Journal: MMW Fortschritte der Medizin 20030529
Title: Mizolastine in primary acquired cold urticaria.
Journal: Journal of the American Academy of Dermatology 20030401
Title: Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine.
Journal: Allergy 20021101
Title: Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020901
Title: Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
Journal: British journal of clinical pharmacology 20020301
Title: A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020201
Title: [Hepatotoxicity of mizolastine (Mizollen) : report of 2 cases].
Journal: Gastroenterologie clinique et biologique 20011201
Title: UV erythema reducing capacity of mizolastine compared to acetylsalicylic acid or both combined in comparison to indomethacin.
Journal: Photochemistry and photobiology 20011001
Title: Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).
Journal: Allergy 20010701
Title: Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children.
Journal: Journal of pharmacokinetics and pharmacodynamics 20010601
Title: One-year treatment of chronic urticaria with mizolastine: efficacy and safety. J Eur Acad Dermatol Venereol 2000; 14: 83-90.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20010101
Title: Clinical pharmacokinetics of mizolastine.
Journal: Clinical pharmacokinetics 20010101
Title: Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine.
Journal: British journal of pharmacology 20001101
Title: Antiallergic effects of H1-receptor antagonists.
Journal: Allergy 20000101
Title: Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 19990101
Title: Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 19980701
Title: Prakash A, et al. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs. 1998 Jul;10(1):41-63.
